Prostate Cancer: Fusion Biopsy

NEW YORK. (Ivanhoe Newswire) -- For decades, doctors have diagnosed prostate cancer using what’s been called a ‘blind’ biopsy, removing and testing a dozen tiny tissue samples to see if cancer is present. Now, new technology is taking the guesswork out of the procedure by allowing doctors to precisely target suspicious areas where deadly cells may be lurking.
Source: Medical Headlines From Ivanhoe.com - Category: Consumer Health News Source Type: news